Come up with a name for your new list and we'll add to it:
Bioharmony Therapeutics raised a round of funding on December 18, 2017. Investors include
Accelerate NY Seed Fund.
Bioharmony Therapeutics is a biopharmaceutical company focused on the discovery and development of lysin-based antimicrobial therapeutics for patients with multi-drug resistant Gram-negative bacterial…